Literature DB >> 9721919

The role of neuronal nitric oxide synthase in cocaine-induced conditioned place preference.

Y Itzhak1, J L Martin, M D Black, P L Huang.   

Abstract

Previous studies suggested the involvement of the neuronal nitric oxide synthase (nNOS) in the development of sensitization to psychostimulants. In the present study we investigated the role of nNOS in the rewarding properties of cocaine. Swiss Webster mice treated with cocaine (20 mg/kg) and saline every other day for 8 days (four drug and four saline sessions) developed conditioned place preference (CPP) for the drug-paired compartment of the cage. Pretreatment with the nNOS inhibitor, 7-nitroindazole (7-NI; 25 mg/kg), completely blocked cocaine-induced CPP. Mice deficient for the nNOS gene (homozygote nNOS(-/-) mice) were resistant to cocaine-induced CPP, while wild-type nNOS(+/+) mice developed a marked CPP following cocaine administration. Both, the pharmacological and genetic manipulations of nNOS suggest that nitric oxide (NO) is involved in the rewarding properties of cocaine.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9721919     DOI: 10.1097/00001756-199808030-00011

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  16 in total

1.  Prenatal exposure to cocaine alters the development of conditioned place-preference to cocaine in adult mice.

Authors:  C J Malanga; Martina Pejchal; Barry E Kosofsky
Journal:  Pharmacol Biochem Behav       Date:  2007-06-21       Impact factor: 3.533

2.  Ethanol-induced conditioned place preference, but not aversion, is blocked by treatment with D -penicillamine, an inactivation agent for acetaldehyde.

Authors:  Laura Font; Carlos M G Aragon; Marta Miquel
Journal:  Psychopharmacology (Berl)       Date:  2005-12-13       Impact factor: 4.530

3.  Rewarding properties of sildenafil citrate in mice: role of the nitric oxide-cyclic GMP pathway.

Authors:  Pouya Tahsili-Fahadan; Noushin Yahyavi-Firouz-Abadi; Amir Hossein Orandi; Behnaz Esmaeili; Zahra Basseda; Ahmad Reza Dehpour
Journal:  Psychopharmacology (Berl)       Date:  2006-01-20       Impact factor: 4.530

4.  Gene transfer of the neuronal NO synthase isoform to cirrhotic rat liver ameliorates portal hypertension.

Authors:  Q Yu; R Shao; H S Qian; S E George; D C Rockey
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

5.  Psychomotor stimulant effects of cocaine in rats and 15 mouse strains.

Authors:  Morgane Thomsen; S Barak Caine
Journal:  Exp Clin Psychopharmacol       Date:  2011-10       Impact factor: 3.157

Review 6.  Molecular genetics of addiction and related heritable phenotypes: genome-wide association approaches identify "connectivity constellation" and drug target genes with pleiotropic effects.

Authors:  George R Uhl; Tomas Drgon; Catherine Johnson; Chuan-Yun Li; Carlo Contoreggi; Judith Hess; Daniel Naiman; Qing-Rong Liu
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

7.  Acquisition and reconditioning of ethanol-induced conditioned place preference in mice is blocked by the H₂O₂ scavenger alpha lipoic acid.

Authors:  Juan Carlos Ledesma; Carlos M G Aragon
Journal:  Psychopharmacology (Berl)       Date:  2012-08-11       Impact factor: 4.530

8.  Molecular genetics of successful smoking cessation: convergent genome-wide association study results.

Authors:  George R Uhl; Qing-Rong Liu; Tomas Drgon; Catherine Johnson; Donna Walther; Jed E Rose; Sean P David; Ray Niaura; Caryn Lerman
Journal:  Arch Gen Psychiatry       Date:  2008-06

9.  Role of the nNOS gene in ethanol-induced conditioned place preference in mice.

Authors:  Yossef Itzhak; Concepción Roger-Sánchez; Karen L Anderson
Journal:  Alcohol       Date:  2009-04-11       Impact factor: 2.405

Review 10.  Asymmetric dimethylarginine (ADMA)--a modulator of nociception in opiate tolerance and addiction?

Authors:  Anousheh Kielstein; Dimitrios Tsikas; Gantt P Galloway; John E Mendelson
Journal:  Nitric Oxide       Date:  2007-06-07       Impact factor: 4.427

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.